A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1
Open Access
- 29 August 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 5 (1), 3-13
- https://doi.org/10.1093/jmcb/mjs049
Abstract
Dysregulation of microRNAs is a common feature in human cancers, including breast cancer (BC). Here we describe the epigenetic regulation of miR-148a and miR-152 and their impact on BC cells. Due to the hypermethylation of CpG island, the expression levels of both miR-148a and miR-152 (miR-148a/152) are decreased in BC tissues and cells. DNMT1, the DNA methyltransferase 1 for the maintenance methylation, is aberrantly up-regulated in BC and its overexpression is responsible for hypermethylation of miR-148a and miR-152 promoters. Intriguingly, we found that DNMT1 expression, which is one of the targets of miR-148a/152, is inversely correlated with the expression levels of miR-148a/152 in BC tissues. Those results lead us to propose a negative feedback regulatory loop between miR-148a/152 and DNMT1 in BC. More importantly, we demonstrate that IGF-IR and IRS1, often overexpressed in BC, are two novel targets of miR-148a/152. Overexpression of miR-148a or miR-152 significantly inhibits BC cell proliferation, colony formation, and tumor angiogenesis via targeting IGF-IR and IRS1 and suppressing their downstream AKT and MAPK/ERK signaling pathways. Our results suggest a novel miR-148a/152-DNMT1 regulatory circuit and reveal that miR-148a and miR-152 act as tumor suppressors by targeting IGF-IR and IRS1, and that restoration of miR-148a/152 expression may provide a strategy for therapeutic application to treat BC patients.Keywords
This publication has 52 references indexed in Scilit:
- MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesisNucleic Acids Research, 2011
- Expression of IGF1R in normal breast tissue and subsequent risk of breast cancerBreast Cancer Research and Treatment, 2011
- Epigenetic Silencing of miR-137 Is an Early Event in Colorectal CarcinogenesisCancer Research, 2010
- SUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 ReceptorScience Signaling, 2010
- Promoter methylation and the detection of breast cancerCancer Causes & Control, 2009
- Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancerThe Journal of Pathology, 2007
- Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2Molecular and Cellular Biology, 2006
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Epigenetics in human disease and prospects for epigenetic therapyNature, 2004